Breast Neoplasm Female Clinical Trials

15 recruiting

Breast Neoplasm Female Trials at a Glance

15 actively recruiting trials for breast neoplasm female are listed on ClinicalTrialsFinder across 6 cities in 13 countries. The largest study group is Not Applicable with 8 trials, with the heaviest enrollment activity in Aalborg, Aarhus, and Adelaide. Lead sponsors running breast neoplasm female studies include Beneficência Portuguesa de São Paulo, Danish Breast Cancer Cooperative Group, and Ahmet Yesildag.

Browse breast neoplasm female trials by phase

Treatments under study

About Breast Neoplasm Female Clinical Trials

Looking for clinical trials for Breast Neoplasm Female? There are currently 15 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Breast Neoplasm Female trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Breast Neoplasm Female clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 115 of 15 trials

Recruiting
Not Applicable

Feasibility and Acceptibility of a Multi-site Trial of Time Restircted Eating During Chemotheraply for Breast Cancer.

Breast CancerBreast Cancer Early Stage Breast Cancer (Stage 1-3)Breast Neoplasm Female
University of Illinois at Chicago40 enrolled2 locationsNCT07387445
Recruiting
Phase 3

A Randomized Trial of Five Fraction Partial Breast Irradiation (RAPID2)

Breast Neoplasm FemaleRadiotherapyCosmetic Outcome
Ontario Clinical Oncology Group (OCOG)910 enrolled28 locationsNCT05417516
Recruiting

A Novel Approach in the Evaluation of Breast Masses With Doppler US

Breast Neoplasm FemaleBenign Breast NeoplasmMalign Breast Neoplasm+1 more
Ahmet Yesildag90 enrolled1 locationNCT07465523
Recruiting
Phase 4

Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response

Breast Neoplasm Female
University of Wisconsin, Madison50 enrolled2 locationsNCT03096418
Recruiting
Not Applicable

RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy

Breast Neoplasm Female
Rna Diagnostics Inc.801 enrolled7 locationsNCT03524430
Recruiting
Not Applicable

The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI

Breast Neoplasm FemaleHereditary Breast and Ovarian Cancer SyndromeEarly Detection of Cancer+1 more
Georgetown University80 enrolled1 locationNCT06892275
Recruiting
Phase 2

Phase II Trial of Disulfiram With Copper in Metastatic Breast Cancer

Metastatic Breast CancerBreast Neoplasm Female
The Institute of Molecular and Translational Medicine, Czech Republic150 enrolled1 locationNCT03323346
Recruiting
Not Applicable

SBRT in Early Breast Cancer in Elderly Women

Breast Neoplasm Female
University of Rome Tor Vergata30 enrolled1 locationNCT05071105
Recruiting
Not Applicable

Delayed-immediate Versus Delayed Breast Reconstruction in Breast Cancer Patients With Mastectomy and Radiation Therapy

Breast Neoplasm FemaleComplication of Radiation TherapyBreast Implant; Complications
Danish Breast Cancer Cooperative Group590 enrolled8 locationsNCT03730922
Recruiting
Not Applicable

Efficacy of Preparation in Self-Hypnosis by Anchoring Versus Conversational Hypnosis, Used Alone or Combined, in Patients Undergoing Breast Macrobiopsies

Breast Neoplasm Female
Hospital St. Joseph, Marseille, France100 enrolled1 locationNCT05027321
Recruiting
Not Applicable

Wearable Enhanced Fitness Tracking for Metastatic Breast Cancer Patients Using Endocrine Treatment and Palbociclib

Quality of LifeBreast Neoplasm Female
Beneficência Portuguesa de São Paulo68 enrolled4 locationsNCT05277935
Recruiting

PRO Survivorship Concerns ITA

Quality of LifeBreast Neoplasm FemalePsychological Distress
Regina Elena Cancer Institute280 enrolled2 locationsNCT06080607
Recruiting
Not Applicable

A Prospective, Open, Multicenter Single-arm Clinical Studie of Docetaxel, Carboplatin Combined With Inetetamab and Pyrotinib in the Treatment of Local-advanced HER2-positive Breast Cancer

Breast Neoplasm Female
Wang Ouchen154 enrolled1 locationNCT06234137
Recruiting
Phase 4

Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients

Breast CancerBreast Cancer FemaleBreast Neoplasms+2 more
Institut fuer Frauengesundheit1,000 enrolled52 locationsNCT05452213
Recruiting
Phase 2

The Efficacy and Safety of Anlotinib Combined With Fulvestrant in Patients With Advanced Breast Cancer

Breast Neoplasm Female
Zhejiang Cancer Hospital40 enrolled1 locationNCT05075512